Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ABACAVIR for Chronic hepatitis c: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 16 adverse event reports in the FDA FAERS database where ABACAVIR was used for Chronic hepatitis c.

Most Reported Side Effects for ABACAVIR

Side Effect Reports % Deaths Hosp.
Exposure during pregnancy 504 11.8% 100 47
Virologic failure 490 11.4% 17 45
Treatment failure 450 10.5% 117 16
Pyrexia 441 10.3% 138 103
Foetal exposure during pregnancy 418 9.8% 63 58
Viral mutation identified 378 8.8% 4 7
Pathogen resistance 367 8.6% 0 16
Rash 349 8.2% 107 33
Hypertension 336 7.9% 125 51
Hypersensitivity 329 7.7% 114 17
Off label use 321 7.5% 110 22
Headache 319 7.5% 109 37
Hepatic enzyme increased 303 7.1% 107 13
Thrombocytopenia 298 7.0% 115 21
Product use issue 297 6.9% 110 15

Other Indications for ABACAVIR

Hiv infection (2,581) Product used for unknown indication (971) Antiretroviral therapy (270) Acquired immunodeficiency syndrome (62) Perinatal hiv infection (38) Foetal exposure during pregnancy (29) Hiv test positive (27) Hiv-2 infection (19) Hepatitis c (16) Hiv infection who clinical stage iii (16)

Other Drugs Used for Chronic hepatitis c

RIBAVIRIN (15,707) PEGINTERFERON ALFA-2A (7,898) LEDIPASVIR\SOFOSBUVIR (6,621) SOFOSBUVIR\VELPATASVIR (6,405) SOFOSBUVIR (6,008) TELAPREVIR (3,103) GLECAPREVIR\PIBRENTASVIR (3,072) SIMEPREVIR (2,735) DACLATASVIR (2,063) PEGINTERFERON ALFA-2B (1,927)

Related Pages

ABACAVIR Full Profile All Chronic hepatitis c Drugs ABACAVIR Demographics ABACAVIR Timeline